Physician profile
Alan Tom
NPI 1912356312
$3,270.44
in general payments reported to CMS, 2019-2025
18 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.38 · 2020: $84.62 · 2021: $336 · 2022: $324 · 2023: $707 · 2024: $934 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472 · Education: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.93 |
| Education | $957.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $957.96 | 2023-2025 | Actis, Mentor Memorygel Resterilizable Gel Sizer, Mentor Memorygel Breast Implant |
| Abbvie INC. | $386.51 | 2023-2024 | Alloderm |
| Allergan, INC. | $215.52 | 2020-2022 | |
| Intuitive Surgical, INC. | $195.49 | 2019-2021 | |
| Tela Bio, INC. | $160.09 | 2024 | Ovitex 2s |
| Davol INC. | $156.63 | 2022 | |
| Acera Surgical, INC. | $152.95 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $148.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Motiva USA, LLC | $141.26 | 2025 | |
| Depuy Synthes Sales INC. | $138.41 | 2023 | Na, Rapidsorb |
| Polynovo North America LLC | $129.00 | 2025 | Novosorb Btm |
| Mentor Worldwide LLC | $120.06 | 2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $114.63 | 2022 | |
| Checkpoint Surgical, INC | $110.86 | 2021 | |
| Integra Lifesciences Corporation | $92.20 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26.18 | 2021 | |
| Acell, INC. | $21.24 | 2020 | |
| Biocomposites INC | $2.59 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Tom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.